Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Nimodipine adverse reaction |
Causative agent (attribute) |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Allergy to nimodipine |
Causative agent (attribute) |
False |
Nimodipine (substance) |
Inferred relationship |
Some |
|
nimodipine 200 microgrammes/mL, fiole de 50 mL pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nimodipine (substance) |
Inferred relationship |
Some |
|
Nimodipine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nimodipine (substance) |
Inferred relationship |
Some |
|
Product containing precisely nimodipine 30 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nimodipine (substance) |
Inferred relationship |
Some |
|
Product containing nimodipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Allergy to nimodipine |
Causative agent (attribute) |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Nimodipine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Nimodipine 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nimodipine 30 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nimodipine 30 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nimodipine 30 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Nimodipine 30 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nimodipine 10 milligram/50 milliliter conventional release solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nimodipine 10 milligram/50 milliliter conventional release solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Product containing nimodipine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Nimodipine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Product containing only nimodipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Product containing only nimodipine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Product containing only nimodipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Nimodipine 200 microgram/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Nimodipine 200 microgram/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nimodipine 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nimodipine 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Nimodipine 200 microgram/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |
Nimodipine 200 microgram/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nimodipine (substance) |
Inferred relationship |
Some |
1 |